---
category: news
title: "Covid treatment using existing drugs developed by LSU AI gets trial approval in UK"
excerpt: "A potential treatment for COVID-19 using existing drugs developed by Skymount Medical using an artificial intelligence platform developed by Louisiana State"
publishedDateTime: 2022-02-22T19:29:00Z
originalUrl: "https://www.brproud.com/news/local-news/covid-treatment-using-existing-drugs-developed-by-lsu-ai-gets-trial-approval-in-uk/"
webUrl: "https://www.brproud.com/news/local-news/covid-treatment-using-existing-drugs-developed-by-lsu-ai-gets-trial-approval-in-uk/"
ampWebUrl: "https://www.brproud.com/news/local-news/covid-treatment-using-existing-drugs-developed-by-lsu-ai-gets-trial-approval-in-uk/amp/"
cdnAmpWebUrl: "https://www-brproud-com.cdn.ampproject.org/c/s/www.brproud.com/news/local-news/covid-treatment-using-existing-drugs-developed-by-lsu-ai-gets-trial-approval-in-uk/amp/"
type: article
quality: 53
heat: 63
published: false

provider:
  name: BR Proud
  domain: brproud.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.brproud.com/wp-content/uploads/sites/80/2022/02/GettyImages-1297202819.jpg?w=1280"
    width: 1280
    height: 787
    isCached: true

related:
  - title: "Skymount garners UK MHRA trial approval for AI-discovered Covid-19 therapeutics"
    excerpt: "The UK MHRA has granted approval to commence a clinical trial of Skymount Medicalâ€™s new oral treatments for mild to moderate Covid-19."
    publishedDateTime: 2022-02-23T12:10:00Z
    webUrl: "https://www.clinicaltrialsarena.com/news/mhra-approval-skymount-trial/"
    type: article
    provider:
      name: Clinical Trials Arena
      domain: clinicaltrialsarena.com
    quality: 37
    images:
      - url: "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2021/02/Freelance-Clinical-Research-Consultants.png"
        width: 800
        height: 450
        isCached: true

secured: "c0kcaI6i5MsgQ6o3iZiEM3mizVWhoBIgozQOnAzHtH/Tb8MyVuTMk4y1g4D+Qjtxm0c/QK/YVFe5Zzd28Iu5imXfhgR0juaGy3iJ3HlJYy2fcYz5+s6bihagG1nSKkzf1WOM/+WMWlNVY2ptRjOjhmOJtcW0S2O49x/2U9lUJMJAEmhTF4lBsRs0Nh2FVglWsJn5pHcPK0QLrOt2vU/PnIPfjm71ovAPxhRRxZX7lXDzMUv4yFWHcETA6yhqSi3cDG+eCWefbaZ6gNHDr3duvdeLXhgfbmPZZCN6B/SZLbNGGBwSsSS39oPm/e/QN9w+QDGAB48e4aONQS3vNklylQMwDXk7GTR6Vw7bca5Srlcs02qaJYApRyEHs0g3rePWzfl6/PZUjiYdDIdqvI+NFbPLqmOenb84Eih6mcZ78XfbVbkKCQbOcJFm9ANG8U/pAvcHgxAe68bqodAYduYPAHcncwv2MLkQxChtn/mUE4eC0z1cginYxpECLzlwSgj/xilmaiINOv+ynZC52nBBnQ==;TidBUtaEFTkH1ylVcwI9gw=="
---

